Interferon-γ, in progression to chronic demyelination and neurological deficit following acute EAE

Molecular and Cellular Neurosciences

Volumn 12, Issue 6, 1998, Pages 376-389

  Renno, Toufic ^a   Taupin, Véronique ^a   Bourbonnière, Lyne ^a   Verge, Gail ^a   Tran, Elise ^a   De Simone, Roberta ^a   Krakowski, Michelle ^a   Rodriguez, Moses ^b   Peterson, Alan ^c   Owens, Trevor ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MAYO CLINIC   (United States)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOPATHOLOGY; DEMYELINATION; DISEASE COURSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0032419459     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.1998.0725     Document Type: Article

References (55)

1. Agresti C., D'Urso D., Levi G. Reversible inhibitory effects of interferon-γ and tumor necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur. J. Neurosci. 8:1996;1106-1116.
2. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., Probert L. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice - Models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 153:1998;801-813.
3. Almazan G., McKay R. An oligodendrocyte precursor cell line from rat optic nerve. Brain Res. 579:1992;234-245.
4. Beck J., Rondot P., Catinot L., Falcoff E., Kirchner H., Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations. Acta Neurol. Scand. 78:1988;318-323.
5. Billiau A., Heremans H., Vandekerckhove F., Dijkmans R., Sobis H., Meulepas E., Carton H. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ J. Immunol. 140:1988;1506-1510.
6. Corbin J. G., Kelly D., Rath E. M., Baerwald K. D., Suzuki K., Popko B. Targeted CNS expression of interferon-γ of transgenic mice leads to hypomyelination, reactive gliosis and abnormal cerebellar development. Mol. Cell. Neurosci. 7:1996;354-370.
7. Ding M., St. Pierre B. A., Parkinson J. F., Medberry P., Wong J. L., Rogers N. E., Ignarro L. J., Merrill J. E. Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia. A kinetic analysis. J. Biol. Chem. 272:1997;11327-11335.
8. Duong T. T., Finkelman F. D., Singh B., Strejan G. H. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53:1994;101-107.
9. Eyer J., Peterson A. Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-beta-galactosidase protein. Neuron. 12:1994;389-405.
10. Ferber I. A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C. G. Mice with a disrupted IFN-γ gene are susceptible to the induction of Experimental Autoimmune Encephalomyelitis (EAE). J. Immunol. 156:1996;5-7.
11. Foran D. R., Peterson A. C. Myelin acquisition in the central nervous system of the mouse revealed by an MBP-Lac Z transgene. J. Neurosci. 12:1992;4890-4897.
12. Frei K., Seipl C., Groscurth P., Schwerdel C., Fontana A. Antigen presentation and tumour cytotoxicity by interferon-γ-treated microglial cells. Eur. J. Immunol. 17:1987;1271-1278.
13. Geiger K., Howes E., Gallina M., Huang X. J., Travis G. H., Sarvetnick N. Transgenic mice expressing IFN-γ in the retina develop inflammation of the eye and photoreceptor loss. Invest. Ophthalmol. Vis. Sci. 35:1994;2667-2681.
14. Gow A., Friedrich V. L. Jr., Lazzarini R. A. Myelin basic protein gene contains separate enhancers for oligodendrocyte and Schwann cell expression. J. Cell Biol. 119:1992;605-616.
15. Gu D., Wogensen L., Calcutt N. A., Xia C., Zhu S., Merlie J. P., Fox H. S., Lindstrom J., Powell H. C., Sarvetnick N. Myasthenia gravis-like syndrome induced by expression of interferon-γ in the neuromuscular junction. J. Exp. Med. 181:1995;547-557.
16. Hayes G. M., Woodroofe M. N., Cuzner M. L. Microglia are the major cell type expressing MHC class II in human white matter. J. Neurol. Sci. 80:1987;25-37.
17. Hickey W. F., Ueno K., Hiserodt J. C., Schmidt R. E. Exogenously-induced, natural killer cell-mediated neuronal killing: A novel pathogenetic mechanism. J. Exp. Med. 176:1992;811-817.
18. Horwitz M. S., Evans C. F., McGavern D. B., Rodriguez M., Oldstone M. B. A. Primary demyelination in transgenic mice expressing Interferon-γ Nature Medicine. 3:1997;1037-1041.
19. Issazadeh S., Mustafa M., Ljungdahl Å., Höjeberg B., Elde R., Dagerlind Å., Olsson T. Interferon-γ, interleukin-4 and transforming growth factor-β in experimental allergic encephalomyelitis in Lewis rats: Dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J. Neurosci. Res. 40:1995;579-590.
20. Kennedy M. K., Torrance D. S., Picha K. S., Mohler K. M. Analysis of cytokine mRNA expression in the central nervous system of mice with Experimental Allergic Encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
21. Krakowski M., Owens T. IFNγ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1996;1641-1646.
22. Martin R., McFarland H. F., McFarlin D. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:1992;153-187.
23. Merrill J. E., Kono D. H., Clayton J., Ando D. G., Hinton D. R., Hofman F. M. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA. 89:1992;574-578.
24. Merrill J. E., Ignarro L. G., Sherman M. P., Melinek J., Lane T. E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
25. Merrill J. E., Benveniste E. N. Cytokines in inflammatory brain lesions: Helpful and harmful. Trends Neurosci. 19:1996;331-338.
26. Neumann H., Cavalié A., Jenne D. E., Wekerle H. Induction of MHC class I genes in neurons. Science. 269:1995;549-552.
27. Neumann H., Schmidt H., Wilharm E., Behrens L., Wekerle H. Interferon γ gene expression in sensory neurons: Evidence for autocrine gene regulation. J. Exp. Med. 186:1997;2023-2031.
28. Okuda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakoda S. Expression of the inducible form of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:1995;103-112.
29. Olsson T., Kristensson K., Ljungdahl A., Maehlen J., Holmdahl R., Klareskog L. Gamma-interferon-like immunoreactivity in axotomized rat motor neurons. J. Neurosci. 9:1989;3870-3875.
30. Owens T., Renno T., Taupin V., Krakowski M. Inflammatory cytokines in the brain: Does the CNS shape immune responses. Immunol. Today. 15:1994;566-571.
31. Owens T., Sriram S. The immunology of MS and of its animal model, EAE. Neurol. Clin. 13:1995;51-73.
32. Panitch H. S., Hirsch R. L., Schindler J., Johnson K. P. Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system. Neurology. 37:1987;1097-1102.
33. Popko B., Puckett C., Lai E., Shine H. D., Readhead C., Takahashi N., Hunt 3d S. W., Sidman R. L., Hood L. Myelin deficient mice: Expression of myelin basic protein and generation of mice with varying levels of myelin. Cell. 48:1987;713-721.
34. Powell M. B., Mitchell D., Lederman J., Buckmeier J., Zamvil S. S., Graham M., Ruddle N. H., Steinman L. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2:1990;539-544.
35. Prineas J. W. The neuropathology of multiple sclerosis. Handbook of Clinical Neurology. 1985;. p. 213-257.
36. Raine C. S. Davies R. L., Robertson D. M. Textbook of Neuropathology. 1990;468-490.
37. low+. Int. Immunol. 6:1994;347-354.
38. Renno T., Krakowski M., Piccirillo C., Lin J.-Y., Owens T. TNFα production by resident microglial cells and infiltrating leukocytes in experimental allergic encephalomyelitis: Regulation by Th1 cytokines. J. Immunol. 154:1995;944-953.
39. Rodriguez M., Lafuse W. P., Leibowitz J., David C. S. Partial suppression of Theiler's virus-induced demyelinationin vivo. Neurology. 36:1986;964-970.
40. Sarvetnick N., Liggitt D., Pitts S. L., Hansen S. E., Stewart T. A. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell. 52:1988;773-782.
41. Sedgwick J. D., Schwender S., Imrich H., Dörries R., Butcher G. W., ter Meulen V. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. USA. 88:1991;7438-7442.
42. Sethna M. P., Lampson L. A. Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-γ J. Neuroimmunol. 34:1991;121-132.
43. Simmons R. D., Willenborg D. O. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100:1990;37-42.
44. Sriram S., Rodriguez M. Indictment of the microglia as the villain in multiple sclerosis. Neurology. 48:1997;464-470.
45. Stalder A. K., Carson M. J., Pagenstecher A., Asensio V. C., Kincaid C., Benedict M., Powell H. C., Masliah E., Campbell I. L. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am. J. Pathol. 153:1998;767-783.
46. Steinman L. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302.
47. Stout R. D. Macrophage activation by T cells: Cognate and noncognate signals. Curr. Opin. Immunol. 5:1993;398-403.
48. Taupin V., Renno T., Bourbonnière L., Peterson A., Rodriguez M., Owens T. Increased severity of EAE, chronic macrophage/microglial reactivity and demyelination in transgenic mice producing tumor necrosis factor-α in central nervous system. Eur. J. Immunol. 27:1997;905-913.
49. Tejada-Berges T., Yong V. W. The astrocyte mitogen, tumor necrosis factor-alpha, inhibits the proliferative effect of more potent adult human astrocyte mitogens, gamma-interferon and activated T-lymphocyte supernatants. Brain Research. 653:1994;297-304.
50. Tran E. H., Hardin-Pouzet H., Verge G., Owens T. Astrocytes and microglia express inducible nitric oxide synthase in mice with Experimental Allergic Encephalomyelitis. J. Neuroimmunol. 74:1997;121-129.
51. Trapp B. D., Peterson J., Ransohoff R. M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. New Engl. J. Med. 338:1998;278-285.
52. Voorthuis J. A. C., Uitdehaag B. M. J., De Groot C. J. A., Goede P. H., van der Meide P. H., Dijkstra C. D. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-γ in Lewis rats. Clin. Exp. Immunol. 81:1990;183-188.
53. Willenborg D. O., Fordham S. C., Bernard C. A., Cowden W. B., Ramshaw I. A. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223-3227.
54. Yong V. W., Moumdjian R., Yong F. P., Ruijs T. C., Freedman M. S., Cashman N., Antel J. A. Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brainin vivo. Proc. Natl. Acad. Sci. USA. 88:1991;7016-7020.
55. Yong V. W., Tejada-Berges T., Goodyer C. G., Antel J. P., Yong F. P. Differential proliferative response of human and mouse astrocytes to gamma-interferon. Glia. 6:1992;269-280.